PURE Bioscience Reports Fiscal Third Quarter 2024 Financial Results
PURE Bioscience, Inc. ("PURE," the "Company" or "we"), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal third quarter ended April 30, 2024. Summary of Results ? Fiscal...
Source: lelezard.com
